Accessibility Menu
 
Pharma-Bio Serv logo

Pharma-Bio Serv

(OTC) PBSV

Current Price$0.48
Market Cap$10.90M
Since IPO (2006)-15%
5 Year-33%
1 Year+27%
1 Month-8%

Pharma-Bio Serv Financials at a Glance

Market Cap

$10.90M

Revenue (TTM)

$4.26B

Net Income (TTM)

$32.75M

EPS (TTM)

$-0.00

P/E Ratio

-144.20

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$0.48

Volume

2

Open

$0.47

Previous Close

$0.48

Daily Range

$0.43 - $0.48

52-Week Range

$0.30 - $1.19

PBSV News

No articles available.

PBSV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharma-Bio Serv

Industry

Life Sciences Tools and Services

Employees

75

CEO

Victor Sanchez, MBA

Headquarters

Dorado, PR 00646, US

PBSV Financials

Key Financial Metrics (TTM)

Gross Margin

30%

Operating Margin

-7%

Net Income Margin

1%

Return on Equity

-68%

Return on Capital

-3%

Return on Assets

0%

Earnings Yield

-0.69%

Dividend Yield

0.00%

Payout Ratio

52.50%

Stock Overview

Market Cap

$10.90M

Shares Outstanding

22.90M

Volume

2

Short Interest

0.00%

Avg. Volume

3.53K

Financials (TTM)

Gross Profit

$2.91M

Operating Income

$637.66K

EBITDA

$134.81K

Operating Cash Flow

$214.89K

Capital Expenditure

$6.64K

Free Cash Flow

$221.53K

Cash & ST Invst.

$10.85M

Total Debt

$28.83K

Pharma-Bio Serv Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.29B

+92763.5%

Gross Profit

$722.37M

+93945.8%

Gross Margin

31.48%

N/A

Market Cap

$10.90M

N/A

Market Cap/Employee

$145.31K

N/A

Employees

75

N/A

Net Income

$32.86M

+384857.8%

EBITDA

$50.35K

-21.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$10.56B

+85890.4%

Accounts Receivable

$2.65M

-1.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

0.24%

N/A

Return on Invested Capital

-3.07%

N/A

Free Cash Flow

$390.14M

-90738.6%

Operating Cash Flow

$390.14M

-90738.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPLTFSpotLite360 IOT Solutions, Inc.
$0.08+0.00%
VYNDVynleads, Inc.
$0.43+0.00%
VPTDFVentriPoint Diagnostics Ltd.
$0.08-1.23%
UDOCFUnidoc Health Corp.
$0.08-17.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$172.70-0.03%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About PBSV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.